After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...

Months after Massachusetts voters rejected a ballot question that would permit adults to use and grow certain psychedelic ...

The company announced on 18 February that the trial did not meet its primary endpoint measured by a depression rating scale, ...

Trump’s “first buddy” Elon Musk made a lively, chaotic and unpredictable appearance at the Conservative Political Action ...

has published its final report on Spravato (esketamine) and says the drug would need to be between 25% and 52% cheaper to meet its value threshold. The spray – which was approved by the FDA in ...

The largest life sciences association in the state recognized those driving discovery during its 32nd annual dinner meeting ...

Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday. FDA approves standalone use of J&J's ketamine-derived depression ...

Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...

Spravato has been approved since 2019 for TRD, with its label extended the following year as a rescue therapy for adults with major depressive disorder (MDD) who were at risk of self-harm or suicide.

A new report highlights the changing perceptions of travel media and marketing, exploring how luxury and lifestyle hotel brands can succeed in attracting a dynamically diverse cohort of luxury ...

A new Department of Justice memo warns investigations could begin against state and local governments if they do not comply with updated immigration policies. The memo, obtained by the Associated ...

A Montana judge on Wednesday struck down a state law defining sex in binary terms, finding that the law violated the Montana Constitution’s guarantees of equal protection and privacy. Judge Leslie ...